Come up with a name for your new list and we'll add to it:
Orchard Therapeutics raised a round of funding on November 26, 2016. Investors include
California Institute of Regenerative Medicine.
Orchard Therapeutics (ORTX) is a biotechnology company focused on the development and commercialization of transformative ex-vivo gene therapies for patients with orphan diseases. Orchard's developmen…